PRNewswire
Neurophth Therapeutics Conducts Special Interview with Dr. Satoshi Kashii on World Sight Day
2022-10-13
Alex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxiety
2022-10-13
Gilead and the IAS start second year of partnership to honor champions of stigma-free HIV care services in Asia and Latin America
2022-10-12
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants
2022-10-12
CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market
2022-10-11
Great Bay Bio Announces Official Launch of Site-Specific Integration Platform for Cell Line Development, AlfaCell®
2022-10-11
Integrating Fitbit & MindFi App into Daily Lifestyle Leads to Significant Improvements in Teachers' Mental Wellness – Singapore Study
2022-10-11
AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease
2022-10-02
First Patient in New Zealand Dosed with Illuccix® – Telix's Prostate Cancer Imaging Agent
2022-09-29
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022
2022-09-29
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC
2022-09-29
GC Labs becomes the first Korean laboratory to obtain certification of CDC standardization programs (VDSCP & HoSt)
2022-09-28